Found: 21
Select item for more details and to access through your institution.
Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-1037-1
- By:
- Publication type:
- Article
Transmission patterns of multiple strains producing New Delhi metallo-β-lactamase variants among animals and the environment in live poultry markets.
- Published in:
- One Health Advances, 2024, v. 2, n. 1, p. 1, doi. 10.1186/s44280-024-00050-2
- By:
- Publication type:
- Article
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01307-2
- By:
- Publication type:
- Article
Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11949, doi. 10.3390/ijms231911949
- By:
- Publication type:
- Article
Regulating unfolded protein response activator HAC1p for production of thermostable raw-starch hydrolyzing α-amylase in Pichia pastoris.
- Published in:
- Bioprocess & Biosystems Engineering, 2017, v. 40, n. 3, p. 341, doi. 10.1007/s00449-016-1701-y
- By:
- Publication type:
- Article
Stimulatory effect of ethanol on libertellenone H biosynthesis by Arctic fungus Eutypella sp. D-1.
- Published in:
- Bioprocess & Biosystems Engineering, 2016, v. 39, n. 2, p. 353, doi. 10.1007/s00449-015-1515-3
- By:
- Publication type:
- Article
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 9, p. 1, doi. 10.15252/emmm.202013193
- By:
- Publication type:
- Article
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02240-5
- By:
- Publication type:
- Article
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01938-2
- By:
- Publication type:
- Article
The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS.
- Published in:
- Reproductive Sciences, 2023, v. 30, n. 2, p. 633, doi. 10.1007/s43032-022-01030-w
- By:
- Publication type:
- Article
Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 8, p. 1, doi. 10.1007/s00018-022-04453-5
- By:
- Publication type:
- Article
FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 997, doi. 10.1111/1759-7714.12776
- By:
- Publication type:
- Article
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer.
- Published in:
- Oncogenesis, 2019, v. 8, n. 9, p. N.PAG, doi. 10.1038/s41389-019-0158-7
- By:
- Publication type:
- Article
Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.852044
- By:
- Publication type:
- Article
Regulation of different polyketide biosynthesis by green light in an endophytic fungus of mangrove leaf.
- Published in:
- 3 Biotech, 2017, v. 7, n. 6, p. 1, doi. 10.1007/s13205-017-0996-y
- By:
- Publication type:
- Article
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3758, doi. 10.3390/cancers14153758
- By:
- Publication type:
- Article
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1561, doi. 10.3390/cancers13071561
- By:
- Publication type:
- Article
Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3273, doi. 10.3390/cancers12113273
- By:
- Publication type:
- Article
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1502, doi. 10.3390/cancers11101502
- By:
- Publication type:
- Article
Green Synthesis of Gold Nanoparticles Using Carrageenan Oligosaccharide and Their In Vitro Antitumor Activity.
- Published in:
- Marine Drugs, 2018, v. 16, n. 8, p. 277, doi. 10.3390/md16080277
- By:
- Publication type:
- Article
Glycosaminoglycans from a Sea Snake (Lapemis curtus): Extraction, Structural Characterization and Antioxidant Activity.
- Published in:
- Marine Drugs, 2018, v. 16, n. 5, p. 170, doi. 10.3390/md16050170
- By:
- Publication type:
- Article